Latanoprost Working Standard

(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentethylethyl Ester|(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoic Acid 1-Methylethyl Ester|(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoic Acid 1-Methylethyl Ester;|GAAP Ofteno|isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R)-3-hydroxy-5-phenylpentyl)cyclopentyl)hept-5-enoate|Isopropyl-(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2 -[(3R)-3-hydroxy-5-phenylpenteptenoate|Isopropyl-(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2 -[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoate;|PhXA-41;|PhXA-41; GAAP Ofteno; Xalatan; (15R)-Latanoprost;